PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1990 January; 61(1): 110–119.
PMCID: PMC1971339

Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Abstract

A collaborative, hospital-based case-control study was conducted at 12 participating centres in 10 countries. Based on data from personal interviews of 2,116 women with newly diagnosed breast cancer and 12,077 controls, the relative risk of breast cancer in women who ever used oral contraceptives was estimated to be 1.15 (1.02, 1.29). Estimated values of this relative risk based on data from three developed and seven developing countries were 1.07 (0.91, 1.26) and 1.24 (1.05, 1.47) respectively; these estimates are not significantly different (P = 0.22). Estimates for women under and over age 35 were 1.26 (0.95, 1.66) and 1.12 (0.98, 1.27), respectively, and these estimates are also not significantly different (P = 0.38). Risk was highest in recent and current users and declined with time since last use regardless of use. Risk did not increase with duration of use after stratifying on time since last use. Risk did not increase significantly with increasing duration of use before age 25 or before a first live birth. However, a relative risk of 1.5 that was of borderline statistical significance was observed in women who used oral contraceptives for more than 2 years before age 25. No single source of bias or confounding was identified that could explain the small increases in risk that were observed. Chance alone is also an unlikely explanation. The results could be due to a combination of chance and potential sources of bias, or they could represent a weak causal relationship.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brinton LA, Hoover R, Szklo M, Fraumeni JF., Jr Oral contraceptives and breast cancer. Int J Epidemiol. 1982 Dec;11(4):316–322. [PubMed]
  • Fasal E, Paffenbarger RS., Jr Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst. 1975 Oct;55(4):767–773. [PubMed]
  • Harris NV, Weiss NS, Francis AM, Polissar L. Breast cancer in relation to patterns of oral contraceptive use. Am J Epidemiol. 1982 Oct;116(4):643–651. [PubMed]
  • Janerich DT, Hoff MB. Evidence for a crossover in breast cancer risk factors. Am J Epidemiol. 1982 Nov;116(5):737–742. [PubMed]
  • Jick SS, Walker AM, Stergachis A, Jick H. Oral contraceptives and breast cancer. Br J Cancer. 1989 Apr;59(4):618–621. [PMC free article] [PubMed]
  • Kay CR, Hannaford PC. Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study. Br J Cancer. 1988 Nov;58(5):675–680. [PMC free article] [PubMed]
  • Kelsey JL, Holford TR, White C, Mayer ES, Kilty SE, Acheson RM. Oral contraceptives and breast disease. An epidemiological study. Am J Epidemiol. 1978 Mar;107(3):236–244. [PubMed]
  • La Vecchia C, Decarli A, Fasoli M, Franceschi S, Gentile A, Negri E, Parazzini F, Tognoni G. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br J Cancer. 1986 Aug;54(2):311–317. [PMC free article] [PubMed]
  • Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whatley AS, Rovira EZ. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst. 1987 Dec;79(6):1247–1254. [PubMed]
  • Lees AW, Burns PE, Grace M. Oral contraceptives and breast disease in premenopausal Northern Albertan women. Int J Cancer. 1978 Dec;22(6):700–707. [PubMed]
  • McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer. 1987 Nov;56(5):653–660. [PMC free article] [PubMed]
  • Meirik O, Lund E, Adami HO, Bergström R, Christoffersen T, Bergsjö P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet. 1986 Sep 20;2(8508):650–654. [PubMed]
  • Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol. 1989 Feb;129(2):269–280. [PubMed]
  • Olsson H, Olsson ML, Möller TR, Ranstam J, Holm P. Oral contraceptive use and breast cancer in young women in Sweden. Lancet. 1985 Mar 30;1(8431):748–749. [PubMed]
  • Paffenbarger RS, Jr, Fasal E, Simmons ME, Kampert JB. Cancer risk as related to use of oral contraceptives during fertile years. Cancer. 1977 Apr;39(4 Suppl):1887–1891. [PubMed]
  • Paffenbarger RS, Jr, Kampert JB, Chang HG. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidemiol. 1980 Aug;112(2):258–268. [PubMed]
  • Paul C, Skegg DC, Spears GF, Kaldor JM. Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) 1986 Sep 20;293(6549):723–726. [PMC free article] [PubMed]
  • Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981 Jan;43(1):72–76. [PMC free article] [PubMed]
  • Prentice RL, Thomas DB. On the epidemiology of oral contraceptives and disease. Adv Cancer Res. 1987;49:285–401. [PubMed]
  • Rosenberg L, Miller DR, Kaufman DW, Helmrich SP, Stolley PD, Schottenfeld D, Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. [PubMed]
  • Skegg DC. Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol. 1988 Feb;127(2):205–212. [PubMed]
  • Stadel BV, Rubin GL, Webster LA, Schlesselman JJ, Wingo PA. Oral contraceptives and breast cancer in young women. Lancet. 1985 Nov 2;2(8462):970–973. [PubMed]
  • Vessey MP, McPherson K, Yeates D, Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer. 1982 Mar;45(3):327–331. [PMC free article] [PubMed]
  • Vessey M, Baron J, Doll R, McPherson K, Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. [PMC free article] [PubMed]
  • Vessey MP, McPherson K, Villard-Mackintosh L, Yeates D. Oral contraceptives and breast cancer: latest findings in a large cohort study. Br J Cancer. 1989 Apr;59(4):613–617. [PMC free article] [PubMed]
  • Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res. 1988 Apr 1;48(7):1949–1953. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK